Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  CytoTools AG    T5O

Real-time Quote. Real-time TRADEGATE AG - 07/31 08:00:02 pm
44.6000 EUR   -0.88%
06/17 CYTOTOOLS : DermaTools Biotech GmbH capital increase
06/02 CYTOTOOLS : New advisory board member
03/11 CYTOTOOLS : Updates on European studies and approval status in India..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
47.985(c) 47.395(c) 44.72(c) 44.995(c) 44.6(c) Last
895 398 2 511 1 470 357 Volume
+0.73% -1.23% -5.64% +0.61% -0.88% Change
More quotes
Financials (€)
Sales 2015 1,30 M
EBIT 2015 -0,82 M
Net income 2015 -1,40 M
Finance 2015 1,80 M
Yield 2015 -
Sales 2016 14,9 M
EBIT 2016 8,77 M
Net income 2016 -1,10 M
Finance 2016 1,40 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 63,8x
EV / Sales 2016 5,59x
Capitalization 84,7 M
More Financials
Company
CytoTools AG operates as a technology and associated company, which is engaged in the purchase, management and sale of shareholdings in German technology enterprises.It focuses on investing in enterprises from the health sector, active in the area of research and development of medicaments and... 
More about the company
Latest news on CYTOTOOLS AG
06/29 CYTOTOOLS : gibt positive Ergebnisse der Zwischenauswertung der europäischen Ulc..
06/17 CYTOTOOLS : DermaTools Biotech GmbH capital increase
06/17 CYTOTOOLS : und Altgesellschafter stärken die erfolgreiche Tochter DermaTools Bi..
06/02 CYTOTOOLS : New advisory board member
05/22 CYTOTOOLS : ernennt Dr. Rüdiger Weseloh von Merck Serono zum Aufsichtsrat (DGAP ..
05/13 CYTOTOOLS : Erfolgreicher Dialog mit der amerikanischen Food and Drug Administra..
05/06 CYTOTOOLS : Patent Issued for Apoptotically Active Peptides
04/15 CYTOTOOLS : Rekrutierung von Patienten für Europäische Studien zum diabetischen ..
More news
Sector news : Bio Therapeutic Drugs
07/31 QUINTILES TRANSNATIONAL : Announces Pricing of Secondary Public Offering
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions